Bookmark and Share
Amygdalin (CID 34751) - Compound BioActivity Data
.
BioActivity Outcomes:
Inactive(29)
 
 
Inconclusive(23)
 
 
Unspecified(11)
 
 
Top Targets:
NAD binding 8(2)
 
 
crotonase-lik..(1)
 
 
Bcl-2 like(1)
 
 
23DHB-AMP lg(1)
 
 
Rapamycin bin..(1)
 
 
BioAssay Types:
Screening(13)
 
 
Literature(4)
 
 
BioActivity Types:
IC50(2)
 
 
Data download

Chemical Probe    Active    Inactive    Inconclusive    Unspecified   

Total Bioassays: 63    Data Row: 63   Total Pages: 4   Display: Page     
Sort: [Click the result table header to sort]
#SubstanceActivityBioAssayTargetLinks
OutcomeTypeValue [μM]
1
[SID8149862]
Screen for compounds that induce the human heat shock transcriptional response (HSEluc) [AID1611, Type: other]
View
2
[SID8149862]
Screen for compounds that increase glutamate transport activity in MN-1 cell line (GluUPTAKE) [AID1612, Type: other]
View
3
[SID8149862]
Screen for compounds that inhibit protein aggregation formed by mutant SOD1 (GFPSOD1) [AID1613, Type: other]
View
4
[SID8149862]
Screen for compounds that reduce polyglutamine (polyQ) inclusions in nerve growth factor (NGF)-treated PC12 cells (GFPQ80) [AID1614, Type: other]
View
5
[SID8149862]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubH) [AID1616, Type: other]
View
6
[SID8149862]
Assay to identify inhibitors of polyglutamine-induced caspase-3 activation (CASP3) [AID1583, Type: other]
View
7
[SID8149862]
Yeast cell-based screen for compounds that suppress polyglutamine aggregation in vivo (75Q-TubU) [AID1593, Type: other]
View
8
[SID8149862]
Screen for compounds that correct neuronal dysfunction without cell death as induced by the expression of polyglutamine-expanded, N-terminal huntingtin in C. elegans mechanosensory neurons (HDELENEU) [AID1599, Type: other]
View
9
[SID8149862]
Screen for compounds that selectively inhibit cytochrome c release from purified mitochondria (CytoCRel) [AID1603, Type: other]
View
10
[SID8149862]
Screen for compounds that inhibit polyglutamine induced protein aggregation (AGREG) [AID1604, Type: other]
View
11
[SID8149862]
Screening of compounds showing protective effect against cell death induced by familial amyotrophic lateral sclerosis (FALS)-linked mutantsuperoxide dismutase 1 (SOD1) (ALSOD1) [AID1605, Type: other]
View
12
[SID11537744]
NMR Based Screening Assay for Influenza A RNA Promoter [AID1637, Type: other]
View
13
[SID85787101]
Luminescence Cell-Based Primary HTS to Measure Viability of BJeLR cells [AID2275, Type: screening]
View
14
[SID85787101]
Luminescence Cell-Based Primary HTS to Identify Inhibitors of the Sonic Hedgehog Signaling Pathway [AID2313, Type: screening]
View
15
[SID85787101]
Luminescence Cell-Based Primary HTS to Identify Activators of the Reversal of PD-1 Mediated Inhibitors of T-Cell Inhibition [AID2316, Type: screening]
View
16
[SID85787101]
Luminescence Homogenous Primary HTS to Identify Inhibitors of STK33 Activity [AID2322, Type: screening]
View
17
[SID85787101]
Fluorescence Cell-Based Primary HTS to Measure Inhibition of Y box Binding Protein 1 Expression [AID434959, Type: screening]
View
18
[SID85787101]
Fluorescence Cell-Based Primary HTS to Identify Reactive Oxygen Species Inducers in Cancer Cells Measured in Cell-Based System Using Plate Reader and Imaging Combination - 2044-01_Activator_SinglePoint_HTS_Activity [AID624156, Type: screening]
View
19
[SID92124522]
A screen for compounds that inhibit liver stage malaria [AID624349, Type: other]
View
20
[SID103588799]
IC50 Inhibition of human recombinant MAOA by fluorimetric method [AID409942, Type: Literature]Amine oxidase [flavin-containing] A [gi:113978]
View